These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 12619708)

  • 1. Pathobiochemistry of nephrotic syndrome.
    Tesar V; Zima T; Kalousová M
    Adv Clin Chem; 2003; 37():173-218. PubMed ID: 12619708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New findings on the pathogenesis of nephrotic syndrome (review article)].
    Tesar V; Zima T; Kalousová M
    Sb Lek; 2002; 103(3):379-95. PubMed ID: 12688182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenetic aspectics of nephrotic syndrome].
    Walz G
    Internist (Berl); 2003 Sep; 44(9):1075-82. PubMed ID: 14566460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in the pathogenesis of nephrotic proteinuria.
    Tesar V; Zima T
    Crit Rev Clin Lab Sci; 2008; 45(2):139-220. PubMed ID: 18415815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome.
    Carraro M; Caridi G; Bruschi M; Artero M; Bertelli R; Zennaro C; Musante L; Candiano G; Perfumo F; Ghiggeri GM
    J Am Soc Nephrol; 2002 Jul; 13(7):1946-52. PubMed ID: 12089392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
    Agrawal V; Prasad N; Jain M; Pandey R
    Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of nephrotic syndrome: new insights into molecules acting at the glomerular filtration barrier.
    Zenker M; Machuca E; Antignac C
    J Mol Med (Berl); 2009 Sep; 87(9):849-57. PubMed ID: 19649571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glomerular permeability factors in idiopathic nephrotic syndrome.
    Davin JC
    Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic kidney diseases disclose the pathogenesis of proteinuria.
    Jalanko H; Patrakka J; Tryggvason K; Holmberg C
    Ann Med; 2001 Nov; 33(8):526-33. PubMed ID: 11730159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte differentiation and hereditary proteinuria/nephrotic syndromes.
    Gubler MC
    J Am Soc Nephrol; 2003 Jun; 14 Suppl 1():S22-6. PubMed ID: 12761234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
    Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo expression of podocyte slit diaphragm-associated proteins in nephrotic patients with NPHS2 mutation.
    Zhang SY; Marlier A; Gribouval O; Gilbert T; Heidet L; Antignac C; Gubler MC
    Kidney Int; 2004 Sep; 66(3):945-54. PubMed ID: 15327385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
    Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
    J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-associated nephropathy: experimental models.
    Avila-Casado C; Fortoul TI; Chugh SS
    Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1).
    Kuusniemi AM; Merenmies J; Lahdenkari AT; Holmberg C; Salmela K; Karikoski R; Rapola J; Jalanko H
    Kidney Int; 2006 Oct; 70(8):1423-31. PubMed ID: 16941028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic correlations in the nephrotic syndrome.
    Habib R; Lévy M; Gubler MC
    Paediatrician; 1979; 8(5-6):325-48. PubMed ID: 392406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome.
    Mollet G; Ratelade J; Boyer O; Muda AO; Morisset L; Lavin TA; Kitzis D; Dallman MJ; Bugeon L; Hubner N; Gubler MC; Antignac C; Esquivel EL
    J Am Soc Nephrol; 2009 Oct; 20(10):2181-9. PubMed ID: 19713307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.
    Doublier S; Zennaro C; Musante L; Spatola T; Candiano G; Bruschi M; Besso L; Cedrino M; Carraro M; Ghiggeri GM; Camussi G; Lupia E
    PLoS One; 2017; 12(11):e0188045. PubMed ID: 29155846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.